» Articles » PMID: 30150688

Ethanol and C2 Ceramide Activate Fatty Acid Oxidation in Human Hepatoma Cells

Overview
Journal Sci Rep
Specialty Science
Date 2018 Aug 29
PMID 30150688
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Obesogenic lipids and the sphingolipid ceramide have been implicated as potential cofactors in alcoholic liver disease (ALD) patients. However, the mechanisms by which these lipids modulate lipid trafficking in ethanol-treated human liver cells to promote steatosis, an early stage of ALD, are poorly understood. We measured fatty acid (FA) uptake, triglyceride export, FA synthesis and FA oxidation in human hepatoma (VL-17A) cells in response to ethanol and the exogenous lipids oleate, palmitate and C2 ceramide. We found that in combination with ethanol, both oleate and palmitate promote lipid droplet accumulation while C2 ceramide inhibits lipid droplet accumulation by enhancing FA oxidation. Further, using both a pharmacologic and siRNA approach to reduce peroxisome proliferator-activated receptors α (PPARα) gene expression, we demonstrate that C2 ceramide abrogates ethanol-mediated suppression of FA oxidation through an indirect PPARα mechanism. Together, these data suggest that lipids interact differentially with ethanol to modulate hepatocellular lipid droplet accumulation and may provide novel targets for preventing the earliest stage of alcoholic liver disease, alcoholic steatosis.

Citing Articles

Ceramides Increase Fatty Acid Utilization in Intestinal Progenitors to Enhance Stemness and Increase Tumor Risk.

Li Y, Chaurasia B, Rahman M, Kaddai V, Maschek J, Berg J Gastroenterology. 2023; 165(5):1136-1150.

PMID: 37541526 PMC: 10592225. DOI: 10.1053/j.gastro.2023.07.017.


Alcohol-Induced Glycolytic Shift in Alveolar Macrophages Is Mediated by Hypoxia-Inducible Factor-1 Alpha.

Morris N, Michael D, Crotty K, Chang S, Yeligar S Front Immunol. 2022; 13:865492.

PMID: 35634337 PMC: 9130492. DOI: 10.3389/fimmu.2022.865492.


Caffeic acid dimethyl ether alleviates alcohol-induced hepatic steatosis via microRNA-378b-mediated CaMKK2-AMPK pathway.

Lu J, Zhang Y, Wang Y, Li Y, Wang R, Zhong Y Bioengineered. 2022; 13(4):11122-11136.

PMID: 35481488 PMC: 9208468. DOI: 10.1080/21655979.2022.2060586.


Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.

Way G, Jackson K, Muscu S, Zhou H Cells. 2022; 11(8.

PMID: 35456053 PMC: 9031669. DOI: 10.3390/cells11081374.


Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease.

Yu J, Youn G, Choi J, Kim C, Kim B, Yang S Clin Transl Med. 2021; 11(12):e634.

PMID: 34965016 PMC: 8715831. DOI: 10.1002/ctm2.634.


References
1.
Mak K, Ren C, Ponomarenko A, Cao Q, Lieber C . Adipose differentiation-related protein is a reliable lipid droplet marker in alcoholic fatty liver of rats. Alcohol Clin Exp Res. 2008; 32(4):683-9. DOI: 10.1111/j.1530-0277.2008.00624.x. View

2.
Carr R, Peralta G, Yin X, Ahima R . Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice. PLoS One. 2014; 9(5):e97118. PMC: 4022498. DOI: 10.1371/journal.pone.0097118. View

3.
Correnti J, Juskeviciute E, Swarup A, Hoek J . Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice. Am J Physiol Gastrointest Liver Physiol. 2014; 306(11):G959-73. PMC: 4042116. DOI: 10.1152/ajpgi.00395.2013. View

4.
Nanji A, Mendenhall C, French S . Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res. 1989; 13(1):15-9. DOI: 10.1111/j.1530-0277.1989.tb00276.x. View

5.
OShea R, Dasarathy S, McCullough A . Alcoholic liver disease. Hepatology. 2009; 51(1):307-28. DOI: 10.1002/hep.23258. View